Literature DB >> 8106268

The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.

P Emery1, B Mach, W Reith.   

Abstract

HLA-DRB1 and -DRB3 are two genes encoding two distinct HLA-DR beta chains in the DRw52 family of haplotypes (DR3, DR5, DR13, and DR14). These beta chains determine the structural and functional identity of the two kinds of HLA-DR molecules expressed. The highly polymorphic HLA-DRB1 locus is always expressed at a higher level than the HLA-DRB3 locus, and functional assays indicate that the proximal promoter of DRB1 is indeed more active than that of DRB3. The DNA sequence of the two promoters in nine different DRw52 haplotypes has revealed a stricking allelic conservation as well as characteristic, isotype-specific, conserved-sequence motifs. These isotype-specific differences concern the functionally essential X and Y box motifs of HLA class II promoters, and they do indeed affect binding of specific nuclear factors to the X and Y boxes of DRB1 or DRB3 promoters. Finally, analysis of the activity of various normal and mutated DRB1 or DRB3 promoters indicates that the X box region of these promoters plays a dominant role in controlling the relative levels of HLA-DRB1 and -DRB3 gene expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8106268     DOI: 10.1016/0198-8859(93)90531-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  13 in total

1.  Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes.

Authors:  G Feriotto; C Mischiati; N Bianchi; C Rutigliano; P Giacomini; R Gambari
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

2.  MHC promoter polymorphism in grey wolves and domestic dogs.

Authors:  Karin T Berggren; Jennifer M Seddon
Journal:  Immunogenetics       Date:  2005-03-10       Impact factor: 2.846

3.  Sequence variations in the transcriptional regulatory region and intron1 of HLA-DQB1 gene and their linkage in southern Chinese ethnic groups.

Authors:  Yunping Xu; Qingsong Hu; Zehuan Liu; Yang Shen; Xiaoyi Liu; Bin Lin; Yuping Wu; Shangwu Chen; Anlong Xu
Journal:  Immunogenetics       Date:  2005-09-29       Impact factor: 2.846

4.  Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.

Authors:  Rosa Faner; Eddie James; Laurie Huston; Ricardo Pujol-Borrel; William W Kwok; Manel Juan
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

5.  Catalog of 162 single nucleotide polymorphisms (SNPs) in a 4.7-kb region of the HLA-DP loci in southern Chinese ethnic groups.

Authors:  Xiaoyi Liu; Zehuan Liu; Bin Lin; Yuanyuan Liu; Zhuoxun Chen; Weicong He; Dong Zhong; Anlong Xu
Journal:  J Hum Genet       Date:  2004-01-15       Impact factor: 3.172

6.  Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101.

Authors:  Y Xiao; A M Lazaro; C Masaberg; M Haagenson; C Vierra-Green; S Spellman; S Dakshanamurthy; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2009-04-06

Review 7.  Regulation of major histocompatibility complex class II gene expression, genetic variation and disease.

Authors:  L Handunnetthi; S V Ramagopalan; G C Ebers; J C Knight
Journal:  Genes Immun       Date:  2009-11-05       Impact factor: 2.676

8.  Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes.

Authors:  D P Singal; X Qiu
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

9.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

Authors:  P Silacci; A Mottet; V Steimle; W Reith; B Mach
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India.

Authors:  Neetu Israni; Ravinder Goswami; Avinash Kumar; Rajni Rani
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.